Trevi Therapeutics, Inc. (“Trevi”), a late-stage clinical development company focused on developing Nalbuphine ER for chronic pruritus conditions, was selected to exhibit a poster at the American Society of Nephrology’s Kidney Week 2014, which takes place November 13th-16th at the Pennsylvania Convention Center in Philadelphia, PA.
Help employers find you! Check out all the jobs and post your resume.
